Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 290

1.

Reduced affinity for Isoniazid in the S315T mutant of Mycobacterium tuberculosis KatG is a key factor in antibiotic resistance.

Yu S, Girotto S, Lee C, Magliozzo RS.

J Biol Chem. 2003 Apr 25;278(17):14769-75. Epub 2003 Feb 13.

2.

Antibiotic resistance in Mycobacterium tuberculosis: peroxidase intermediate bypass causes poor isoniazid activation by the S315G mutant of M. tuberculosis catalase-peroxidase (KatG).

Suarez J, Ranguelova K, Schelvis JP, Magliozzo RS.

J Biol Chem. 2009 Jun 12;284(24):16146-55. doi: 10.1074/jbc.M109.005546. Epub 2009 Apr 9.

3.

Resonance Raman spectroscopy of Compound II and its decay in Mycobacterium tuberculosis catalase-peroxidase KatG and its isoniazid resistant mutant S315T.

Kapetanaki SM, Chouchane S, Yu S, Magliozzo RS, Schelvis JP.

J Inorg Biochem. 2005 Jun;99(6):1401-6.

PMID:
15917090
4.

Conformational differences in Mycobacterium tuberculosis catalase-peroxidase KatG and its S315T mutant revealed by resonance Raman spectroscopy.

Kapetanaki S, Chouchane S, Girotto S, Yu S, Magliozzo RS, Schelvis JP.

Biochemistry. 2003 Apr 8;42(13):3835-45.

PMID:
12667074
5.

Catalase-peroxidase (Mycobacterium tuberculosis KatG) catalysis and isoniazid activation.

Chouchane S, Lippai I, Magliozzo RS.

Biochemistry. 2000 Aug 15;39(32):9975-83.

PMID:
10933818
6.

Recombinant Mycobacterium tuberculosis KatG(S315T) is a competent catalase-peroxidase with reduced activity toward isoniazid.

Wengenack NL, Uhl JR, St Amand AL, Tomlinson AJ, Benson LM, Naylor S, Kline BC, Cockerill FR 3rd, Rusnak F.

J Infect Dis. 1997 Sep;176(3):722-7.

7.

Superoxide reactivity of KatG: insights into isoniazid resistance pathways in TB.

Ghiladi RA, Cabelli DE, Ortiz de Montellano PR.

J Am Chem Soc. 2004 Apr 21;126(15):4772-3.

PMID:
15080669
8.

Evidence for differential binding of isoniazid by Mycobacterium tuberculosis KatG and the isoniazid-resistant mutant KatG(S315T).

Wengenack NL, Todorovic S, Yu L, Rusnak F.

Biochemistry. 1998 Nov 10;37(45):15825-34.

PMID:
9843388
9.

Mycobacterium tuberculosis KatG(S315T) catalase-peroxidase retains all active site properties for proper catalytic function.

Kapetanaki SM, Chouchane S, Yu S, Zhao X, Magliozzo RS, Schelvis JP.

Biochemistry. 2005 Jan 11;44(1):243-52.

PMID:
15628865
10.

Hydrogen peroxide-mediated isoniazid activation catalyzed by Mycobacterium tuberculosis catalase-peroxidase (KatG) and its S315T mutant.

Zhao X, Yu H, Yu S, Wang F, Sacchettini JC, Magliozzo RS.

Biochemistry. 2006 Apr 4;45(13):4131-40.

PMID:
16566587
11.

Redox potential measurements of the Mycobacterium tuberculosis heme protein KatG and the isoniazid-resistant enzyme KatG(S315T): insights into isoniazid activation.

Wengenack NL, Lopes H, Kennedy MJ, Tavares P, Pereira AS, Moura I, Moura JJ, Rusnak F.

Biochemistry. 2000 Sep 19;39(37):11508-13.

PMID:
10985797
12.

Characterization of the binding of isoniazid and analogues to Mycobacterium tuberculosis catalase-peroxidase.

Zhao X, Yu S, Magliozzo RS.

Biochemistry. 2007 Mar 20;46(11):3161-70. Epub 2007 Feb 20.

PMID:
17309235
13.

Isoniazid-resistance conferring mutations in Mycobacterium tuberculosis KatG: catalase, peroxidase, and INH-NADH adduct formation activities.

Cade CE, Dlouhy AC, Medzihradszky KF, Salas-Castillo SP, Ghiladi RA.

Protein Sci. 2010 Mar;19(3):458-74. doi: 10.1002/pro.324.

15.
16.

Carbon monoxide adducts of KatG and KatG(S315T) as probes of the heme site and isoniazid binding.

Lukat-Rodgers GS, Wengenack NL, Rusnak F, Rodgers KR.

Biochemistry. 2001 Jun 19;40(24):7149-57.

PMID:
11401561
17.
18.

Characterization of the katG and inhA genes of isoniazid-resistant clinical isolates of Mycobacterium tuberculosis.

Rouse DA, Li Z, Bai GH, Morris SL.

Antimicrob Agents Chemother. 1995 Nov;39(11):2472-7.

19.

Molecular characterization of isoniazid-resistant Mycobacterium tuberculosis isolates collected in Australia.

Lavender C, Globan M, Sievers A, Billman-Jacobe H, Fyfe J.

Antimicrob Agents Chemother. 2005 Oct;49(10):4068-74.

20.

Spectroscopic comparison of the heme active sites in WT KatG and its S315T mutant.

Lukat-Rodgers GS, Wengenack NL, Rusnak F, Rodgers KR.

Biochemistry. 2000 Aug 15;39(32):9984-93.

PMID:
10933819
Items per page

Supplemental Content

Write to the Help Desk